XCUR
Price:
$2.31
Market Cap:
$14.72M
Exicure, Inc. is a biotechnology firm that utilizes its unique spherical nucleic acid (SNA) platform to create therapies for neurological conditions and hair loss. Its primary experimental candidate, SCN9A, is currently undergoing preclinical evaluation for addressing neuropathic and chronic pain. The company has entered into a strategic partnership with AbbVie Inc. to advance SNA-based solutions for various hair loss conditions, under a collaboration, option, and license agreement. Additionally, a separate collaborative effort with Ipsen S.A. aims to investigate, develop, and commercialize novel spherical nucleic acids targeting Huntington's disease and Angelman syndrome. Established in 201...[Read more]
Industry
Biotechnology
IPO Date
2018-05-22
Stock Exchange
NASDAQ
Ticker
XCUR
According to Exicure, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.47. This represents a change of -56.73% compared to the average of -3.40 of the last 4 quarters.
The mean historical PE Ratio of Exicure, Inc. over the last ten years is -21.52. The current -1.47 PE Ratio has changed 583.13% with respect to the historical average. Over the past ten years (40 quarters), XCUR's PE Ratio was at its highest in in the March 2020 quarter at 185.00. The PE Ratio was at its lowest in in the September 2017 quarter at -79.08.
Average
-21.52
Median
-20.77
Minimum
-55.56
Maximum
-1.37
Discovering the peaks and valleys of Exicure, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 634.87%
Maximum Annual PE Ratio = -1.37
Minimum Annual Increase = -95.53%
Minimum Annual PE Ratio = -55.56
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -6.86 | -20.20% |
| 2024 | -8.60 | 525.54% |
| 2023 | -1.37 | -86.61% |
| 2022 | -10.27 | 634.87% |
| 2021 | -1.40 | -95.53% |
| 2020 | -31.27 | -0.28% |
| 2019 | -31.36 | -3.62% |
| 2018 | -32.54 | -41.43% |
| 2017 | -55.56 | 54.48% |
| 2016 | -35.96 | -22.35% |
The current PE Ratio of Exicure, Inc. (XCUR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.61
5-year avg
-5.70
10-year avg
-21.52
Exicure, Inc.’s PE Ratio is less than Klotho Neurosciences, Inc. (-1.08), less than Sonnet BioTherapeutics Holdings, Inc. (-0.32), greater than iBio, Inc. (-2.94), less than MetaVia Inc. (-0.27), less than CollPlant Biotechnologies Ltd. (-0.33), less than Cadrenal Therapeutics, Inc. Common Stock (-0.62), greater than Rallybio Corporation (-10.72), greater than NeurAxis, Inc. (-8.94), greater than NeuroSense Therapeutics Ltd. (-3.00), less than TAO Synergies Inc. (-0.27),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.08 | $20.08M | |
| -0.32 | $8.43M | |
| -2.94 | $26.68M | |
| -0.27 | $3.52M | |
| -0.33 | $4.12M | |
| -0.62 | $10.04M | |
| -10.72 | $92.63M | |
| -8.94 | $88.55M | |
| -3.00 | $19.85M | |
| -0.27 | $12.06M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exicure, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Exicure, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Exicure, Inc.'s PE Ratio?
How is the PE Ratio calculated for Exicure, Inc. (XCUR)?
What is the highest PE Ratio for Exicure, Inc. (XCUR)?
What is the 3-year average PE Ratio for Exicure, Inc. (XCUR)?
What is the 5-year average PE Ratio for Exicure, Inc. (XCUR)?
How does the current PE Ratio for Exicure, Inc. (XCUR) compare to its historical average?